Evidence map›Paper›PMID 39555924›Full record

ArticleJournal of clinical microbiology2024

Retrospective analysis of antimicrobial susceptibility profiles of non-

Ryan B Khodadadi, Said El Zein, Christina G Rivera O'Connor, Ryan W Stevens, Audrey N Schuetz, Omar M Abu Saleh, Madiha Fida

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Septic arthritis due toASM case reports · 2026
    Article
  4. An underestimated pathogen:Journal of clinical microbiology · 2025
    Review
  5. In Vitro Activity of Delafloxacin AgainstAntibiotics (Basel, Switzerland) · 2025
    Article
  6. IDCases · 2025
    Article
  7. Therapeutic advances in respiratory disease
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ryan B KhodadadiDivision of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0003-1903-6700
Said El ZeinDivision of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0003-4331-5259
Christina G Rivera O'ConnorDepartment of Pharmacy, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0002-8308-3264
Ryan W StevensDepartment of Pharmacy, Mayo Clinic, Rochester, Minnesota, USA.
Audrey N SchuetzDivision of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0002-5837-270X
Omar M Abu SalehDivision of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Madiha FidaDivision of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0002-3630-0668

Funding

Mayo Clinic Center for Clinical and Translational Science (CCaTS UL1 Supplement - Dr. Timothy Curry)UL1TR002377 · NCATS · MAYO CLINIC ROCHESTER · PI VESNA D GAROVIC · 2017 to 2026
$78.4M
NCATS NIH HHS UL1 TR002377
6 · The paper itself

Abstract

A total of 1,925

Indexed as

Anti-Bacterial AgentsCorynebacteriumCorynebacterium InfectionsMicrobial Sensitivity TestsTertiary Care CentersAdolescentAdultAgedAged, 80 and overChildChild, PreschoolDrug Resistance, BacterialFemaleHumansInfantMaleAnti-Bacterial AgentsantibioticantimicrobialCorynebacteriumresistancesusceptibility

Identifiers

PMID39555924
PMCPMC11633113

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.